Morgan and Mendel Genomics, Inc. — Department of Defense SBIR Phase I: AF212-CSO1
Morgan and Mendel Genomics, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $49,955
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF212-CSO1
- Solicitation
- X21.2
- NAICS
- —
- Place of performance
- DE
- Period
- 2021-11-03 → 2022-02-07
Description
Morgan and Mendel Genomics (MMG) is a functional genomics company developing cutting edge science to identify genetic disruptions in human cells with high sensitivity and specificity, low cost, and rapid performance time. MMG’s two novel blood tests, Canc